Old Web
English
Sign In
Acemap
>
authorDetail
>
Steve K Murray
Steve K Murray
Medicine
Immune system
Autoantibody
Platelet
Immunology
2
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract A19: A phase 1, multicenter, dose-escalation study of PRN1371, an irreversible covalent FGFR1-4 kinase inhibitor, in patients with advanced solid tumors including metastatic urothelial carcinoma (mUC)
2020
Clinical Cancer Research
Sarina Anne Piha-Paul
Cinta Hierro
Ignacio Matos
Valentina Boni
Noah M. Hahn
Rhonda L. Bitting
Todd W. Bauer
Aggarwal Rahul
Funda Meric-Bernstam
Steven G. Gourlay
Timothy D. Owens
Ken A. Brameld
Ann Neale
Richard Schwartz
Steve K Murray
Sibel Ucpinar
Peter Foote
Eleni Venetsanakos
Josep Tabernero
Show All
Source
Cite
Save
Citations (0)
PRN1008, a Reversible Covalent BTK Inhibitor in Clinical Development for Immune Thrombocytopenic Purpura
2017
Blood
Claire L. Langrish
J. Michael Bradshaw
Timothy D. Owens
Robert L. Campbell
Michelle Francesco
Dane E. Karr
Steve K Murray
Robert C Quesenberry
Patrick F. Smith
Michael D. Taylor
Jiang Zhu
Philip A. Nunn
Steven G. Gourlay
Show All
Source
Cite
Save
Citations (14)
1
map